KRRO Stock: Korro Bio, Inc. Stock Price, Analysis & Insights
Get live krro stock price $6.50, comprehensive Korro Bio, Inc. stock analysis, charts, news, and expert forecast. Real-time krro stock data and investment insights.
Loading chart...
Company Overview
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.
Company Information
- CEO
- Ram Aiyar MBA,
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 112
Contact Information
- Website
- https://www.korrobio.com
- Address
- One Kendall Square
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 2.21)
Business Model & Strategy
Korro Bio, Inc. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Ram Aiyar MBA,, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Korro Bio, Inc. competes in the Biotechnology within the broader Healthcare. With 61.0 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Capital Market, Korro Bio, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Korro Bio, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Korro Bio, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Korro Bio, Inc.
- ⚠Investors should consider how Korro Bio, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
61.04M
P/E Ratio
-0.67
Beta
2.21
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 61.04M market capitalization
- Trading Volume: 8.08M shares traded today
- Price Range: 52-week range of $6.04 - $56.69
- Exchange: Listed on NASDAQ Capital Market
Financial Metrics
Market Analysis for Korro Bio, Inc.
Korro Bio, Inc. (KRRO) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 61.04M, the company represents a significant player in its market. The stock is currently trading at $6.50 with a negativedaily change of 79.31%.
The company's 112 employee base and presence on the NASDAQ Capital Marketexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.67, beta of 2.21, and 52-week price range from $6.04 to $56.69when evaluating investment opportunities.
Why Invest in Korro Bio, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Capital Market)
- • Experienced leadership under Ram Aiyar MBA,
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.